American BioMed (ABMI) a strong buy recommendation of $5-6

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
American BioMed (ABMI) a strong buy recommendation of $5-6

An SI Board Since June 1996

Posts	SubjectMarks	Bans
463	1	0

Emcee: Bob Lee	Type: Unmoderated

Introduction Compact

Does anyone have any info on this one?

THE WOODLANDS, Texas--(BUSINESS WIRE)--June 6, 1996--Strategic
Advisory Inc. announced today that they have initiated coverage on
American BioMed Inc. (OTC BB: ABMI), of The Woodlands, Texas.
Strategic has instituted a strong buy recommendation with a 12
to 18 month target valuation of $5 to $6 per share. The company
analyst stated that American BioMed Inc. will be highlighted in
Strategic's mid-June newsletter as well as the August publication of
Individual Investor.
ABMI is a company that is just beginning to commercialize its
vascular product lines. These products include but are not limited
to patented and unique products such as stents, catheters and the
OmniCath, ABMI's atherectomy catheter.
Stents are the new wave in cardiology. These small devices use
self-expanding nitinol that helps keep blood vessels open after an
angioplasty has been performed. This does not infringe on Johnson &
Johnson's (NYSE:JNJ) balloon delivered stents. ABMI is also
positioning itself as the premier provider of silicone based
catheters. Their nine FDA approved catheters are silicone based and
have broad uses.
The OmniCath is an atherectomy device which actually removes
plaque buildup from blood vessels. It vacuums and filters preventing
distally embolisms and thereby helps return blood flow back to normal
levels. The analyst also cites added valuation due to the recent
stock acquisition of InStent Inc. (NASDAQ:ININ) for $214.6 million
by Medtronic Inc. (NYSE:MDT) due to the similarity of the stent
delivery systems of InStent and American BioMed.
The OmniCath is currently being marketed in Europe and is in
stage two of the FDA approval process and is about to submit its
510-K filing in order to speed up the process which will fully
commercialize the unit in the United States.
--30--eh/sf* cmf/sf
CONTACT:
Strategic Advisory Inc.
Brendon Gebben, 800/793-2601

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
463	Isn't about time for your annual post?	Cisco	-	1/11/2003
462	Is that still you?	Zoltan!	-	5/9/2002
461	You passed!	SIer formerly known as Joe B.	-	1/27/2002
460	Nope, not banned <b>or</b&g	Graystone	-	1/26/2002
459	test	Jill Munden	-	1/22/2002
458	New Thread: By Jeffrey Henken! Subject 19556 Brenda Greer	Brenda L. Greer	-	3/2/1998
457	To all I will be putting together a new ABMI thread soon. new investors are tak	Jeffrey L. Henken	-	3/1/1998
456	They needed some news like this.Now they are making a product for someone else	Greg Zielinski	-	2/18/1998
455	Finally some good news. This company is really alive!!! biz.yahoo.com Enjoy,	Brian Slaybaugh	-	2/18/1998
454	It looks like the only thing that is going to make this one take off is a good	Greg Zielinski	-	2/17/1998
453	Anytime in the next 45 days. Maybe next week.	Larry E Smith	-	2/13/1998
452	anyone know when earnings are due for this manipulated piece of dookie?	advinfo	-	2/13/1998
451	Might as well go to the new one.	Larry E Smith	-	1/5/1998
450	This seems so unusual that everybody is holding fast. Buyers won't pay the	Dan Dieffenwierth	-	1/5/1998
449	Nothing is going on. Just someone sold 1000 shares for some reason. Probably w	Larry E Smith	-	1/5/1998
448	Larry, do you know what's going on? I only see 1000 shares traded today at	Dan Dieffenwierth	-	1/5/1998
447	I agree with you. I still have those $2 shares and it hurts a little but I,ve g	Larry E Smith	-	1/2/1998
446	There is no hype now, but there was plenty of hype when I bought on the way up	Doug Meetmer	-	1/2/1998
445	Where is the hype! I don't see any. This is one of the slowest boards on th	Larry E Smith	-	1/2/1998
444	Greg, I appreciate your opinion, however, I disagree. This company has has pl	Doug Meetmer	-	1/1/1998
443	Just about even on the bulls and bears with this stock. I am bullish long term	Larry E Smith	-	1/1/1998
442	Doug ABMI is going to take of in 1998 to bad you didn't ride it out. I hav	Greg Zielinski	-	1/1/1998
441	To bad you couldn'nt hang on for the ride back up next year. I hope you go	Brian Slaybaugh	-	1/1/1998
440	Well, I sold this dog today. At least I can recapture 1/3 of my losses. Now o	Doug Meetmer	-	12/31/1997
439	To one and all: and a happy new year.......	Larry E Smith	-	12/25/1997

Go to reply# or date (mm/dd/yy):